AbbVie’s One-Pill Combo Therapy Shows Promise for Hepatitis C in Japanese Trial
Hepatitis C, News
AbbVie’s new hepatitis C treatment candidate, a one tablet combination of the investigational drugs glecaprevir and pibrentasvir, harnessed the infection in all patients who completed a Japanese study. The treatment, ... Read more